Evidence map›Paper›PMID 38928474›Full record

ArticleInternational journal of molecular sciences2024

α-Chitosan and β-Oligochitosan Mixtures-Based Formula for In Vitro Assessment of Melanocyte Cells Response.

Verginica Schröder, Daniela Gherghel, Manuela Rossemary Apetroaei, Cristiana Luminița Gîjiu, Raluca Isopescu, Daniel Dinculescu, Miruna-Maria Apetroaei, Laura Elena Enache, Cosmin-Teodor Mihai, Ileana Rău and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Chitosan Biomaterials: Advances and Challenges-2nd Edition.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Verginica SchröderDepartament of Cellular and Molecular Biology, Faculty of Pharmacy, Ovidius University of Constanta, 6 Capt. Aviator Al. Șerbănescu Street, Campus C, 900470 Constanta, Romania.ORCID 0000-0001-8876-1901
Daniela GherghelInstitute of Biological Research Iasi, Branch of NIRDBS-National Institute of Research and Development of Biological Sciences Bucharest, 47 Lascar Catargi, 700107 Iasi, Romania.
Manuela Rossemary ApetroaeiDepartment of Marine Electric and Electronic Engineering, Faculty of Marine Engineering, Mircea cel Batran Naval Academy, 1 Fulgerului Street, 900218 Constanta, Romania.ORCID 0000-0002-7446-7899
Cristiana Luminița GîjiuFaculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.
Raluca IsopescuFaculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.
Daniel DinculescuFaculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.
Miruna-Maria ApetroaeiFaculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania.
Laura Elena EnacheFaculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.ORCID 0009-0001-7407-2774
Cosmin-Teodor MihaiPraxis Medical Investigations, Moara de Vant St. 35, 700376 Iasi, Romania.ORCID 0000-0002-0945-5437
Ileana RăuFaculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, 011061 Bucharest, Romania.ORCID 0000-0002-0780-9502
Gabriela VochițaInstitute of Biological Research Iasi, Branch of NIRDBS-National Institute of Research and Development of Biological Sciences Bucharest, 47 Lascar Catargi, 700107 Iasi, Romania.ORCID 0000-0002-0876-473X

Funding

Romanian Ministry of Education and Research, CNCS-UEFISCDI and partially from Romanian Ministry of Research, Innovation and Digitization Core-Program project number PN-III-P4-ID-PCE-2020-2243 and project 7N/23020402/2023
6 · The paper itself

Abstract

Chitosan is a natural polymer with numerous biomedical applications. The cellular activity of chitosan has been studied in various types of cancer, including melanoma, and indicates that these molecules can open new perspectives on antiproliferative action and anticancer therapy. This study analyzes how different chitosan conformations, such as α-chitosan (CH) or β-oligochitosan (CO), with various degrees of deacetylation (DDA) and molar mass (MM), both in different concentrations and in CH-CO mixtures, influence the cellular processes of SK-MEL-28 melanocytes, to estimate the reactivity of these cells to the applied treatments. The in vitro evaluation was carried out, aiming at the cellular metabolism (MTT assay), cellular morphology, and chitinase-like glycoprotein YKL-40 expression. The in vitro effect of the CH-CO mixture application on melanocytes is obvious at low concentrations of α-chitosan/β-oligochitosan (1:2 ratio), with the cell's response supporting the hypothesis that β-oligo-chitosan amplifies the effect. This oligochitosan mixture, favored by the β conformation and its small size, penetrates faster into the cells, being more reactive when interacting with some cellular components. Morphological effects expressed by the loss of cell adhesion and the depletion of YKL-40 synthesis are significant responses of melanocytes. β-oligochitosan (1.5 kDa) induces an extension of cytophysiological effects and limits the cell viability compared to α-chitosan (400-900 kDa). Statistical analysis using multivariate techniques showed differences between the CH samples and CH-CO mixtures.

Indexed as

ChitinChitinase-3-Like Protein 1ChitosanMelanocytesOligosaccharidesCell Line, TumorCell ProliferationCell SurvivalHumansMelanomaCHI3L1 protein, humanChitinChitinase-3-Like Protein 1ChitosanoligochitosanOligosaccharidesSK-MEL-28 melanocytesYKL-40α-chitosanβ-oligochitosan

Identifiers

PMID38928474
PMCPMC11204147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.